Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children
- PMID: 658106
- DOI: 10.1007/BF00609754
Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children
Abstract
Steady state serum concentrations of digoxin were determined repeatedly in 34 infants with congenital heart disease. Simultaneous measurements of renal clearances of digoxin, creatinine and urea were obtained in 29 of the subjects. Serum digoxin concentrations were markedly higher in children under the age of 3 months than in those over this age, despite equal weight--adjusted 24 h doses. This finding was explained by a very rapid increase in renal digoxin clearance in the first 3 months--32 +/- 7 ml/min/1.73m2 at 1 week to 65.6 +/- 30 at 3 months. The subsequent increase in digoxin clearance was much slower, e. g. to 87.7 +/- 43 ml/min/1.73m2 at 12 months. Renal clearance of digoxin was equally well correlated with creatinine clearance (r = 0.87) as with urea clearance (r = 0.83), but it exceeded that of creatinine in all age groups. The findings indicate that both glomerular and tubular function is involved in the renal elimination of digoxin in young children, and that development of renal elimination of the drug parallels that of the maturation of renal function in the early months of life. The neonate and infant with congestive heart failure display impaired ability to eliminate digoxin. The impairment lessens rapidly with the development of renal function over the first 3 months of life. Diminished doses of digoxin should be advocated in this age group if therapeutic serum concentrations of the drug are to be maintained and toxicity avoided.
Similar articles
-
Renal clearance of digoxin in young infants.Res Commun Chem Pathol Pharmacol. 1977 Feb;16(2):363-74. Res Commun Chem Pathol Pharmacol. 1977. PMID: 847290
-
Renal clearance of digoxin in premature neonates.Res Commun Chem Pathol Pharmacol. 1981 Nov;34(2):207-16. Res Commun Chem Pathol Pharmacol. 1981. PMID: 7335951
-
Maturation and renal digoxin clearance.Clin Pharmacol Ther. 1981 Dec;30(6):735-8. doi: 10.1038/clpt.1981.231. Clin Pharmacol Ther. 1981. PMID: 7307424
-
Digoxin pharmacokinetics and dosage requirements in pediatric patients.Clin Pharm. 1983 May-Jun;2(3):224-35. Clin Pharm. 1983. PMID: 6349908 Review.
-
Clinical pharmacokinetics of digoxin.Clin Pharmacokinet. 1977 Jan-Feb;2(1):1-16. doi: 10.2165/00003088-197702010-00001. Clin Pharmacokinet. 1977. PMID: 322907 Review.
Cited by
-
Developmental pharmacokinetics in pediatric populations.J Pediatr Pharmacol Ther. 2014 Oct-Dec;19(4):262-76. doi: 10.5863/1551-6776-19.4.262. J Pediatr Pharmacol Ther. 2014. PMID: 25762871 Free PMC article. Review.
-
The pharmacokinetics of digoxin in newborn and adult sheep.J Pharmacokinet Biopharm. 1982 Apr;10(2):173-86. doi: 10.1007/BF01062334. J Pharmacokinet Biopharm. 1982. PMID: 7120047
-
Pharmacokinetics of cardiovascular drugs in children. Inotropes and vasopressors.Clin Pharmacokinet. 1994 Nov;27(5):345-67. doi: 10.2165/00003088-199427050-00003. Clin Pharmacokinet. 1994. PMID: 7851053 Review.
-
Development of a paediatric population-based model of the pharmacokinetics of rivaroxaban.Clin Pharmacokinet. 2014 Jan;53(1):89-102. doi: 10.1007/s40262-013-0090-5. Clin Pharmacokinet. 2014. PMID: 23912563 Free PMC article. Clinical Trial.
-
Dosing Recommendations for Pediatric Patients With Renal Impairment.J Clin Pharmacol. 2020 Dec;60(12):1551-1560. doi: 10.1002/jcph.1676. Epub 2020 Jun 15. J Clin Pharmacol. 2020. PMID: 32542790 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources